These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 19237907

  • 1. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N, Kaestle S, Yin J, Hentschel T, Pries AR, Kuppe H, Kuebler WM.
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [Abstract] [Full Text] [Related]

  • 2. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [Abstract] [Full Text] [Related]

  • 3. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N, Lundin S, Ricksten SE.
    J Heart Lung Transplant; 1995 Mar; 14(3):436-43. PubMed ID: 7654728
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
    Baysal A, Bilsel S, Bulbul OG, Kayacioglu I, Idiz M, Yekeler I.
    Heart Surg Forum; 2006 Mar; 9(1):E536-42. PubMed ID: 16387672
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
    Antoniou T, Koletsis EN, Prokakis C, Rellia P, Thanopoulos A, Theodoraki K, Zarkalis D, Sfyrakis P.
    J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
    [Abstract] [Full Text] [Related]

  • 6. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.
    Sablotzki A, Czeslick E, Schubert S, Friedrich I, Mühling J, Dehne MG, Grond S, Hentschel T.
    Can J Anaesth; 2002 Dec; 49(10):1076-80. PubMed ID: 12477682
    [Abstract] [Full Text] [Related]

  • 7. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbruck B, Grimminger F, Seeger W.
    Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
    [Abstract] [Full Text] [Related]

  • 8. Effects of inhaled aerosolized iloprost and inhaled NO on pulmonary circulation and edema formation in ovine lung injury.
    Hucklenbruch C, Hinder F, Berger C, Ertmer C, Lange M, Westphal M, Van Aken H, Ellger B, Dirk Stubbe H.
    Shock; 2008 Jul; 30(1):75-80. PubMed ID: 18562927
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
    Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W.
    J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
    [Abstract] [Full Text] [Related]

  • 10. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, Beygui R, Shemin R, Watson L, Vartapetian I, Ardehali A.
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
    [Abstract] [Full Text] [Related]

  • 11. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction.
    Antoniou T, Prokakis C, Athanasopoulos G, Thanopoulos A, Rellia P, Zarkalis D, Kogerakis N, Koletsis EN, Bairaktaris A.
    Ann Thorac Surg; 2012 Sep; 94(3):792-8. PubMed ID: 22727248
    [Abstract] [Full Text] [Related]

  • 12. Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases.
    Sablotzki A, Hentschel T, Hofmann S, Simm A, Mühling J, Czeslick E.
    J Clin Anesth; 2006 Mar; 18(2):108-13. PubMed ID: 16563327
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S, Schrötter H, Schmeisser A, Strasser RH.
    Int J Cardiol; 2007 Jan 31; 115(1):67-72. PubMed ID: 16797747
    [Abstract] [Full Text] [Related]

  • 14. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
    Limsuwan A, Khosithseth A, Wanichkul S, Khowsathit P.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):98-104. PubMed ID: 19089967
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
    Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J, Hamm M, Fabel H.
    N Engl J Med; 2000 Jun 22; 342(25):1866-70. PubMed ID: 10861321
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.